Capítulo V: Discusión y conclusiones
Gráfica 4: Diagnóstico sobre Comunicación con las Familias
Current research surrounding evidence reversal terms and definitions has concentrated on the field of Medicine; however, comparing new high quality evidence to previous
evidence is an inherent part of advancing all research – and not limited to Medicine – we expand the term to include any and all evidence. The framework proposed in this thesis provides a summarization of all current research surrounding evidence reversal by aggregating and pairing terms and with definitions. This summation in turn informs classification, level, traits, proposed actions and recommendations for evidence.
Validation and use of this framework could assist in universality and generalizability of future research into Evidence Reversal while increasing the quality of this research. Previously obtained research related to evidence reversal from Chapter 2 is primarily low to very low quality as scored by AMSTAR tool. 2.3.6 This rating is due to inclusion of collections of studies, not only systematic research. To build confidence in the
recommendations of the field of Evidence Reversal, future research must be of higher quality with better transparency of methods and data extraction.
Evidence reversals have been identified in the evidence base, but their underlying causes have yet to be investigated. Identification of their underlying causes could help develop and validate a predictive tool for risk of reversal or improve research in general as the evidence base and quality measures mature.
Current measures for evidence maturity require a wealth of research on a topic to determine sufficiency and stability, while most topics encounter a dearth of research. Alternate measures for maturity for use with a scarcity of evidence must be developed.
3.6
Bibliography
1. National Institute for Health and Care Excellence (NICE). (n.d.-b). UK Database of Uncertainties about the Effects of Treatments (UK DUETs) [Database]. Retrieved July 22, 2014, from http://www.library.nhs.uk/duets/
2. National Institute for Health and Care Excellence (NICE). (n.d.-a). National Institute for Health and Care Excellence (NICE) “Do not do” List [Database]. Retrieved July 22, 2014, from
http://www.nice.org.uk/savingsAndProductivity/collection?page=1&pageSize=10 &type=Do_not_do&published=&impact=&filter=
3. Advancing Medical Professionalism to Improve Health Care Foundation (ABIM). (n.d.). The American Board of Internal Medicine (ABIM) Foundation Initiative Choosing Wisely [Database]. Retrieved July 22, 2014, from
http://www.choosingwisely.org/about-us/
4. The Canadian Medical Association (CMA). (n.d.). The Canadian Medical Association (CMA) Campaign Choosing Wisely [Database]. Retrieved July 22, 2014, from http://www.choosingwiselycanada.org/
5. The British Medical Journal (BMJ). (n.d.). The BMJ’s Too Much Medicine [Database]. Retrieved July 22, 2014, from http://www.bmj.com/too-much- medicine
6. Australian Government Department of Health and Ageing, Medicare. (n.d.). Australian Government Department of Health and Ageing, Medicare
“Comprehensive Management Framework” environmental scan [Database]. Retrieved July 22, 2014, from
http://www.health.gov.au/internet/main/publishing.nsf/Content/New_MBS_Items 7. U.S. Preventive Services Task Force (USPSTF). (n.d.). U.S. Preventive Services
Task Force (USPSTF) “Grade ‘D’ recommendations” for preventive health services [Database]. Retrieved July 22, 2014, from
http://www.uspreventiveservicestaskforce.org/Page/Name/recommendations 8. Sutton, D., & Martin, J. (2014). Evidence reversal: when new evidence
contradicts established practices. PROSPERO 2014: CRD42014013768. Retrieved July 22, 2014, from
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD4201401376 8
9. Prasad, V., Vandross, A., Toomey, C., et al. (2013). A Decade of Reversal: An Analysis of 146 Contradicted Medical Practices. Mayo Clinic Proceedings, 88(8), 790–798. http://doi.org/10.1016/j.mayocp.2013.05.012
10.Prasad, V. (2011). The Frequency of Medical Reversal. Archives of Internal Medicine, 171(18), 1675. http://doi.org/10.1001/archinternmed.2011.295
11.Shea, B. J., Grimshaw, J. M., Wells, G. A., et al (2007). Development of AMSTAR: A Measurement Tool to Assess the Methodological Quality of Systematic Reviews. BMC Medical Research Methodology. 7:10.
http://dx.doi.org/10.1186/1471-2288-7-10 and Checklist
http://amstar.ca/Amstar_Checklist.php
12.Prasad, V., Cifu, A., & Ioannidis, J. P. A. (2012). Reversals of Established Medical Practices: Evidence to Abandon Ship. JAMA, 307(1), 37.
13.Prasad, V., & Cifu, A. (2012). A medical burden of proof: Towards a new ethic. BioSocieties, 7(1), 72–87. http://doi.org/10.1057/biosoc.2011.25
14.Bryson, G. L. (2014). Back to the future: medical reversals and perioperative medicine. Canadian Journal of Anesthesia/Journal Canadien D’anesthésie, 61(3), 215–219. http://doi.org/10.1007/s12630-013-0103-8
15.Fatovich, D. M. (2013). Medical reversal: What are you doing wrong for your patient today? Emergency Medicine Australasia, 25(1), 1–3.
http://doi.org/10.1111/1742-6723.12044
16.Prasad, V., & Cifu, A. (2011). Medical reversal: why we must raise the bar before adopting new technologies. The Yale Journal of Biology and Medicine, 84(4), 471 – 478.
17.Prasad, V., & Cifu, A. (2013). The reversal of cardiology practices: interventions that were tried in vain. Cardiovascular Diagnosis and Therapy, 3(4), 228–35.
http://doi.org/10.3978/j.issn.2223-3652.2013.10.05.
18.Wellbery, C., & McAteer, R. (2013). When medicine reverses itself: avoiding practice pitfalls. American Family Physician, 88(11), 733–738.
19.Ioannidis, J. P. A., & Trikalinos, T. A. (2005). Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials. Journal of Clinical Epidemiology, 58(6), 543–549. http://doi.org/10.1016/j.jclinepi.2004.10.019 20.Ioannidis, J. P. A. (2006). Evolution and Translation of Research Findings: From
Bench to Where? PLoS Clinical Trials, 1(7), e36.
http://doi.org/10.1371/journal.pctr.0010036
21.Ioannidis, J. P. A. (2005). Molecular Bias. European Journal of Epidemiology, 20(9), 739–745. http://doi.org/10.1007/s10654-005-2028-1
22.Ioannidis, J. P. A. (2005). Contradicted and Initially Stronger Effects in Highly Cited Clinical Research. JAMA, 294(2), 218.
http://doi.org/10.1001/jama.294.2.218
23.Prasad, V., & Ioannidis, J. P. (2014). Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices. Implementation Science, 9(1), 1. http://doi.org/10.1186/1748-5908-9-1
24.Ioannidis, J. P. A. (2011). Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses. JAMA, 305(21), 2200. http://doi.org/10.1001/jama.2011.713 25.Trikalinos, T. A., Churchill, R., Ferri, M., et al (2004). Effect sizes in cumulative
meta-analyses of mental health randomized trials evolved over time. Journal of Clinical Epidemiology, 57(11), 1124–1130.
http://doi.org/10.1016/j.jclinepi.2004.02.018
26.Ioannidis, J. P. A., Trikalinos, T., Ntzani, E., & Contopoulos-Ioannidis, D. (2003). Genetic associations in large versus small studies: an empirical assessment. The Lancet, 361(9357), 567–71.
27.Ioannidis, J. P. A. (2007). Non-Replication and Inconsistency in the Genome- Wide Association Setting. Human Heredity, 64(4), 203–213.
28.Shojania, K. G. (2007). How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis. Annals of Internal Medicine, 147(4), 224.
http://doi.org/10.7326/0003-4819-147-4-200708210-00179
29.Thorlund, K., Devereaux, P. J., Wetterslev, J., et al. (2009). Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
International Journal of Epidemiology, 38(1), 276–286.
http://doi.org/10.1093/ije/dyn179
30.Venkatesh, A. K., & Schuur, J. D. (2013). A “Top Five” list for emergency medicine: a policy and research agenda for stewardship to improve the value of emergency care. The American Journal of Emergency Medicine, 31(10), 1520– 1524. http://doi.org/10.1016/j.ajem.2013.07.019
31.Kotzeva, A., Almazan, C., Colls, C., et al. (2013, November). Adding value to health care through discontinuation of low-value practices: ESSENCIAL Project in Catalonia. Presented at the International Joint Conference: 2nd Conference of International Society for EBHC, 6th International Conference for EBHC Teachers and Developers, Taormina (Italy).
http://www.ebhcconference.org/files/slides/01.11/04.KOTZEVA_ANNA_PROT ETTO.pdf
32.Scott, I. A., & Elshaug, A. G. (2013). Foregoing low-value care: how much evidence is needed to change beliefs? Internal Medicine Journal, 43(2), 107–109.
http://doi.org/10.1111/imj.12065
33.Elshaug, A. G., Watt, A. M., Mundy, L., & Willis, C. D. (2012). Over 150 potentially low-value health care practices: an Australian study. The Medical Journal of Australia, 197(10), 556–560. http://doi.org/10.5694/mja12.11083
34.Elshaug, A. G., McWilliams, J. M., & Landon, B. E. (2013). The Value of Low- Value Lists. JAMA, 309(8), 775. http://doi.org/10.1001/jama.2013.828
35.Haas, M., Hall, J., Viney, R., & Gallego, G. (2012). Breaking up is hard to do: why disinvestment in medical technology is harder than investment. Australian Health Review, 36(2), 148. http://doi.org/10.1071/AH11032
36.Loder, E., Weizenbaum, E., Frishberg, B., Silberstein, S., & American Headache Society Choosing Wisely Task Force. (2013). Choosing Wisely in Headache Medicine: The American Headache Society’s List of Five Things Physicians and Patients Should Question. Headache: The Journal of Head and Face Pain, 53(10), 1651–1659. http://doi.org/10.1111/head.12233
37.Elshaug, A. G., Moss, J. R., Littlejohns, P., et al. (2009). Identifying existing health care services that do not provide value for money. The Medical Journal of Australia, 190(5), 269–273.
38.Doust, J. (2004). Why do doctors use treatments that do not work? British
Medical Journal, 328(7438), 474–475. http://doi.org/10.1136/bmj.328.7438.474 39.Wootton, S. H., Evans, P. W., & Tyson, J. E. (2013). Unproven Therapies in
Clinical Research and Practice: The Necessity to Change the Regulatory
Paradigm. Pediatrics, 132(4), 599–601. http://doi.org/10.1542/peds.2013-0778 40.Makic, M. B. F., VonRueden, K. T., Rauen, C. A., & Chadwick, J. (2011).
Evidence-Based Practice Habits: Putting More Sacred Cows Out to Pasture. Critical Care Nurse, 31(2), 38–62. http://doi.org/10.4037/ccn2011908
41.Makic, M. B. F., Rauen, C., Watson, R., & Poteet, A. W. (2014). Examining the Evidence to Guide Practice: Challenging Practice Habits. Critical Care Nurse, 34(2), 28–45. http://doi.org/10.4037/ccn2014262
42.Makic, M. B. F., Martin, S. A., Burns, S., et al. (2013). Putting Evidence Into Nursing Practice: Four Traditional Practices Not Supported by the Evidence. Critical Care Nurse, 33(2), 28–42. http://doi.org/10.4037/ccn2013787
43.Arbour, R., Bridges, E., Chulay, M., et al. (2008). Seven evidence-based practice habits: putting some sacred cows out to pasture. Critical Care Nurse, 28(2), 98– 123.
44.McCandless, D. (n.d.-a). Snake Oil Superfoods? [Data Visualization]. Retrieved from http://www.informationisbeautiful.net/visualizations/snake-oil-superfoods/ 45.McCandless, D. (n.d.-b). Snake Oil Supplements? [Data Visualization]. Retrieved
from http://www.informationisbeautiful.net/visualizations/snake-oil-supplements/ 46.McCandless, D. (n.d.-c). Snake Oil Version 2 [Data Visualization]. Retrieved
from http://www.informationisbeautiful.net/2011/snake-oil-version-2/ 47.Macleod, M. R., Michie, S., Roberts, I., et al. (2014). Biomedical research:
increasing value, reducing waste. The Lancet, 383(9912), 101–104.
http://doi.org/10.1016/S0140-6736(13)62329-6
48.Tricoci, P. (2009). Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines. JAMA, 301(8), 831. http://doi.org/10.1001/jama.2009.205 49.Ioannidis, J. P. A., & Lau, J. (2001). Evolution of treatment effects over time:
empirical insight from recursive cumulative metaanalyses. Proceedings of the National Academy of Sciences of the United States, 98(3), 831–6.
http://doi.org/10.1073/pnas.98.3.831
50.Ray, I. B. (2012). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 12(Fall), 185–187.
51.Ray, I. B. (2013). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 13(Fall), 288–292.
52.Ray, I. B. (2013). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 13(Spring), 3–7.
53.Ray, I. B. (2014). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 14(Spring), 3–6.
54.Ray, I. B. (2013). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 13(Summer), 176–180.
55.Ray, I. B. (2014). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 14(Summer), 148–153.
56.Ray, I. B. (2012). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 12(Winter), 294–297.
57.Ray, I. B. (2013). Advancing Evidence-Based Practice: A Quarterly Compilation of Research Updates Most Likely to Change Clinical Practice. The Ochsner Journal, 13(Winter), 478–480.
58.Elshaug, A. G. (2007). Building the Evidence Base for Disinvestment from Ineffective Health Care Practices: A Case Study in Obstructive Sleep Apnoea Syndrome (Thesis (Ph.D.)). University of Adelaide, School of Population Health and Clinical Practice, School of Population Health and Clinical Practice : Public Health. Retrieved from http://hdl.handle.net/2440/47974
59.Elshaug, A. G., Hiller, J. E., Tunis, S. R., & Moss, J. R. (2007). Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Australia and New Zealand Health Policy, 4(1), 23.
http://doi.org/10.1186/1743-8462-4-23
60.Dent, L., Taylor, R., Jolly, K., & Raftery, J. (2011). “Flogging dead horses”: evaluating when have clinical trials achieved sufficiency and stability? A case study in cardiac rehabilitation. Trials, 12(1), 83. http://doi.org/10.1186/1745- 6215-12-83
61.Muellerleile, P., & Mullen, B. (2006). Sufficiency and Stability of Evidence for Public Health Interventions Using Cumulative Meta-Analysis. American Journal of Public Health, 96(3), 515–522. http://doi.org/10.2105/AJPH.2003.036343
62.Sutton, D., & Martin, J. (In Press). Evidence Reversal: The Merits of Skepticism in Evidence-Based Medicine. Western Research Forum Publication.
63.Higgins, J., & Green, S. (2011). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. Cochrane. http://handbook.cochrane.org/
64.Sterne, J. A. C., Higgins, J. P. T., & Reeves, B. C. (2014). A Cochrane Risk Of Bias Assessment Tool: for Non-Randomized Studies of Interventions
(ACROBAT-NRSI), Version 1.0.0. Cochrane. http://www.riskofbias.info 65.Balshem, H., Helfand, M., Schunemann, H. J., et al. (2011). GRADE guidelines:
3. Rating the quality of evidence. Journal of Clinical Epidemiology. 64(4):401- 406. http://dx.doi.org/10.1016/j.jclinepi.2010.07.015
66.Lau, J., Antman, E. M., Jimenez-Silva, J., et al. (1992). Cumulative Meta-
Analysis of Therapeutic Trials for Myocardial Infarction. NEJM. 327(4):248-254. 67.Mukherjee, D., Nissen, S. E., & Topol, E. J. (2001). Risk of Cardiovascular
Events Associated With Selective COX-2 Inhibitors. JAMA, 286(8), 954.